2014 Журнал "Почки" №4 (6)

Ôàðìàêîëîã³÷íà åíöèêëîïåä³ÿ / Pharmacological Encyclopedia
55. Plinitz V. Intraindividual comparison of moxonidine and
prazosin in hypertensive patients // Eur. J. Clin. Pharmacol. 1986;
29 (6): 645-50.
56. Trieb G., Jаger B., Hughes P.R. et al. Longterm evaluation
of the antihypertensive efficacy and tolerability of the orally acting
imidazoline I 1
receptor agonist moxonidine in patients with mild-tomoderate
essential hypertension // Eur. J. Clin. Res. 1995; 7: 227-40.
57. Rayner B., Goetzer E. Moxonidine is effective for controlling
blood pressure in patients with resistant hypertension [abstract] //
Cardiovasc. J. S. Afr. 2005 Mar; 16 (2 Suppl. 1): 20.
58. Martin U., Hill C., O’Mahony D. Use of moxonidine in elderly
patients with resistant hypertension // J. Clin. Pharm. Ther. 2005 Oct;
30 (5): 433-7.
59. Cohn J.N., Pfeffer M.A., Rouleau J. et al. Adverse mortality
effect of central sympathetic inhibition with sustained-release moxonidine
in patients with heart failure (MOXCON) // Eur. J. Heart Fail.
2003; 5 (5): 659-67.
60. Confirmation of the effectiveness and tolerability profile of the
antihypertensive moxonidine: data from 14 post-marketing surveillancestudies
involving > 91,000 patients. Hannover: Solvay Pharmaceuticals,
2005. (Data on file)
61. Reaven G.M. Insulin resistance/compensatory hyperinsulinemia,
essential hypertension, and cardiovascular disease // J. Clin.
Endocrinol. Metab. 2003; 88 (6): 2399-403.
62. Peverill R.E. Hypertension guidelines, metaanalyses and clinical
trials: do we assume too much // Med. J. Aust. 2005; 182 (2):
82-4.
63. Opie L.H., Schall R. Old antihypertensives and new diavetes
// J. Hypertens. 2004; 22: 1543-8.
64. Rayner B. Selective imidazoline agonist moxonidine plus the
ACE inhibitor ramipril in hypertensive patients with impaired insulin
sensivity: partners in a successful MARRIAGE // Curr. Med. Res.
Opin. 2004 Mar; 20 (3): 359-67.
65. Messerli F.H., Grossman E., Leonetti G. Antihypertensive
therapy and new onset diabetes // J. Hypertens. 2004; 22: 1845-7.
66. Kanja R.J., Pöyhönen-Alho MK. Insulin resistance and sympathetic
overactivity in women // J. Hypertens. 2005; 24: 131-41.
67. Pater C., Bnatnagar D., Berrou J.-P. et al. A novel approach
to treatment of hypertensive in diabetic patients: a multicenter, doubleblind,
randomized study comparing the efficacy of combination
therapy of eprosartan versus ramipril with low-dose hydrochlorothiazide
and moxonidine on blood pressure levels in patients with hypertension
and associated diabetes mellitus type 2. Rationale and design
[ISRCTN55725285] // Curr. Control. Trials Cardiovasc. Med. 2004
Oct 1; 5 (1): 9.
Получено 22.10.13
¹ 4 (6) • 2013
www.mif-ua.com 81